2017-03-16,Inotek Pharmaceuticals Corporation Reports Fiscal Year 2016 Financial Results And Operational Highlights
2017-03-06,INVESTOR ALERT: Levi & Korsinsky, LLP Reminds Investors It Has Filed A Class Action Lawsuit Against Inotek Pharmaceuticals Corporation And A Lead Plaintiff Deadline Of March 7, 2017 - ITEK
2017-02-27,Inotek Pharmaceuticals Announces Participation At Upcoming Investor Conferences
2017-02-24,URGENT: Monteverde & Associates PC Invites Inotek Pharmaceuticals Corporation Shareholders With Losses To Contact The Firm Immediately - ITEK
2017-02-24,Inotek Pharmaceuticals Announces Poster Presentations On Trabodenoson At The American Glaucoma Society 2017 Annual Meeting
2017-02-22,INVESTOR ALERT: Levi & Korsinsky, LLP Reminds Investors It Has Filed A Class Action Lawsuit Against Inotek Pharmaceuticals Corporation And A Lead Plaintiff Deadline Of March 7, 2017
2017-02-17,ITEK SHAREHOLDER ALERT: The Law Offices Of Vincent Wong Reminds Investors Of Commencement Of A Class Action Involving Inotek Pharmaceuticals Corporation And A Lead Plaintiff Deadline Of March 7, 2017
2017-02-14,Bragar Eagel & Squire, P.C. Reminds Investors That A Class Action Lawsuit Has Been Filed Against Inotek Pharmaceuticals Corporation (ITEK) And Encourages Investors With Losses To Contact The Firm
2017-02-13,ITEK INVESTOR ALERT: The Law Offices Of Vincent Wong Reminds Investors Of A Class Action Involving Inotek Pharmaceuticals Corporation And A Lead Plaintiff Deadline Of March 7, 2017
2017-02-10,Inotek Pharmaceuticals To Present At The BIO CEO And Investor Conference
2017-02-06,Bragar Eagel & Squire, P.C. Announces That A Class Action Lawsuit Has Been Filed Against Inotek Pharmaceuticals Corporation (ITEK) And Encourages Investors To Contact The Firm
2017-02-06,SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Investors It Has Filed A Class Action Lawsuit Against Inotek Pharmaceuticals Corporation And A Lead Plaintiff Deadline Of March 7, 2017
2017-02-02,ITEK SHAREHOLDER ALERT: The Law Offices Of Vincent Wong Notifies Investors Of A Class Action Involving Inotek Pharmaceuticals Corporation And A Lead Plaintiff Deadline Of March 7, 2017
2017-02-02,SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses In Excess Of $100,000 Investing In Inotek Pharmaceuticals Corporation To Contact The Firm Before Lead Plaintiff Deadline
2017-01-20,Johnson & Weaver, LLP Initiates Investigations Of Rent-A-Center, Inc., KalVista Pharmaceuticals, Inc., NovoCure Limited And Inotek Pharmaceuticals Corp.
2017-01-18,Lifshitz & Miller Law Firm Announces Investigation Of DaVita Inc., First NBC Bank Holdings Company, Fresenius Medical Care AG & Co. KGAA, Inotek Pharmaceuticals Corporation, Natural Health Trends Corp., NeoPhotonics Corporation, NewLink Genetics Corporation And PayPal Holdings, Inc.
2017-01-12,These 5 Stocks Under $10 Could Explode Higher Soon
2017-01-10,INVESTOR ALERT: Lundin Law PC Announces Securities Class Action Lawsuit Against Inotek Pharmaceuticals Corporation And Encourages Investors With Losses To Contact The Firm
2017-01-10,SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Notifies Investors Of Class Action Against Inotek Pharmaceuticals Corporation (ITEK) & Lead Plaintiff Deadline: March 7, 2017
2017-01-09,IMPORTANT INVESTOR ALERT: Goldberg Law PC Announces Securities Class Action Lawsuit Against Inotek Pharmaceuticals Corporation And Encourages Investors With Losses To Contact The Firm
2017-01-04,SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces An Investigation Concerning Possible Violations Of Federal Securities Laws By Certain Officers And Directors Of Inotek Pharmaceuticals Corporation
2017-01-03,Inotek Pharma Shares Plummet Following Negative Glaucoma Trial Results
2017-01-03,Inotek Pharma Glaucoma Drug Suffers Study Setback at Start of New Year
2017-01-03,Inotek Announces Top-line Results For MATrX-1, First Phase 3 Trial Of Trabodenoson For Glaucoma
2017-01-03,17 Thoughts on Biotech Stocks to Kick Off 2017
2016-11-28,Inotek Pharmaceuticals Stock Sees Short Interest Fall 22%
2016-11-22,Oversold Conditions For Inotek Pharmaceuticals (ITEK)
2016-11-10,Inotek Pharmaceuticals Announces Participation At Upcoming Investor Conferences
2016-11-09,Inotek Pharmaceuticals Corporation Reports Third Quarter 2016 Financial Results And Operational Highlights
2016-10-13,Inotek Pharmaceuticals Stock Sees Short Interest Move 20% Higher
2016-10-07,Inotek Pharmaceuticals To Present At The 2016 Ophthalmology Innovation Summit
2016-09-30,Commit To Buy Inotek Pharmaceuticals Corp At $7.50, Earn 41.3% Annualized Using Options
2016-09-29,Inotek Pharmaceuticals Appoints Timothy Barberich To Board Of Directors
2016-09-27,Inotek Pharmaceuticals Stock Sees Short Interest Move 13% Lower
2016-09-15,7 Stocks Under $10 Making Big Moves Higher
2016-09-13,Inotek Pharmaceuticals Stock Sees Short Interest Jump 17.2%
2016-09-09,Inotek Pharmaceuticals Becomes Oversold (ITEK)
2016-09-06,Inotek Pharmaceuticals Announces Participation At Upcoming Investor Conferences
2016-08-24,Inotek Pharmaceuticals Announces The Completion Of The Recruitment Phase Of MATrX-1, The First Phase 3 Clinical Trial Of Trabodenoson For Glaucoma
2016-08-18,Inotek Pharmaceuticals Appoints Patrick Machado, JD, To Board Of Directors
2016-08-10,Inotek Pharmaceuticals Corporation Reports Second Quarter 2016 Financial Results And Operational Highlights
2016-08-02,Notable Tuesday Option Activity: ITEK, WEB, FIT
2016-08-02,Inotek Pharmaceuticals Announces Pricing Of $50.0 Million Of 5.75% Convertible Senior Notes Due 2021
2016-08-01,Inotek Pharmaceuticals Announces Proposed Public Offering Of $50 Million Of Convertible Senior Notes Due 2021
2016-07-22,Inotek Pharmaceuticals Expands Intellectual Property Portfolio With Combination Patent
2016-07-12,Inotek Pharmaceuticals Initiates Phase 2 Dose-ranging Trial Of A Fixed-Dose Combination Of Trabodenoson, A Novel Treatment For Glaucoma, And Latanoprost
2016-07-08,Inotek Pharmaceuticals To Present At Upcoming Investor Conferences
2016-06-16,Inotek Pharmaceuticals Announces Participation In Fireside Chat At JMP Securities 2016 Life Sciences Conference
2016-06-15,Beleaguered Valeant Appoints Lead Independent Director
2016-06-13,RSI Alert: Inotek Pharmaceuticals (ITEK) Now Oversold
2016-05-26,InVentiv Health Elects David Southwell To Company's Board Of Directors
2016-05-11,Inotek Pharmaceuticals Corporation Reports First Quarter 2016 Financial Results And Operational Highlights
2016-04-29,Government Probes for Valeant; New Board Members Put Forth
2016-04-26,Inotek Pharmaceuticals Announces Poster Presentations On Trabodenoson At The ARVO 2016 Annual Meeting
2016-04-21,Inotek Pharmaceuticals Corporation Announces Publication Of Phase 1 Data For Trabodenoson In Healthy Adult Volunteers In The Journal Of Ocular Pharmacology And Therapeutics
2016-04-11,Inotek Pharmaceuticals Announces The Journal Of Ocular Pharmacology And Therapeutics Has Published Its Phase 2 Data For Trabodenoson In Patients With Glaucoma And Ocular Hypertension
2016-04-04,Inotek Pharmaceuticals Announces Changes To Board Of Directors
2016-03-23,Inotek Pharmaceuticals Corporation Reports Fiscal Year 2015 Financial Results And Operational Highlights
2016-03-20,8 Biotech Stocks Under $10 Making Big Moves Higher
2016-03-14,Inotek Pharmaceuticals To Present At GTCbio's 8th Ocular Diseases And Drug Discovery Conference
2016-03-09,Inotek Pharmaceuticals Strengthens Patent Estate For Lead Product Candidate Trabodenoson
2016-02-29,Inotek Pharmaceuticals To Present At Cowen And Company's 36th Annual Health Care Conference
2016-02-24,Inotek Pharmaceuticals Announces Poster Presentation At The American Glaucoma Society's 2016 Annual Meeting
2016-02-05,Inotek Pharmaceuticals is Now Oversold (ITEK)
2016-02-01,Inotek Pharmaceuticals Announces Participation In Ophthalmology Panel At 18th Annual BIO CEO & Investor Conference On February 8th
2016-01-28,Inotek Pharmaceuticals To Present At Glaucoma 360 New Horizons Forum
2016-01-12,Inotek Pharmaceuticals Appoints Carsten Boess To Board Of Directors
2015-12-16,Inotek To Webcast First Research And Development Day
2015-12-11,Buy These 5 Stocks Now to Catch the Breakouts
2015-11-25,Inotek To Host First Research And Development Day In New York City On December 17th, 2015
2015-11-24,Inotek Pharmaceuticals To Present At The Piper Jaffray 27th Annual Healthcare Conference
2015-11-12,Inotek Pharmaceuticals Corporation Reports Third Quarter 2015 Financial Results And Operational Highlights
2015-11-05,Inotek Pharmaceuticals To Present At The 2015 Ophthalmology Innovation Summit
2015-10-30,5 Stocks Ready to Break Out Higher
2015-10-16,Inotek Pharmaceuticals Initiates Dosing Of MATRx-1, The First Pivotal Phase 3 Clinical Trial Of Trabodenoson, A Novel Treatment For Glaucoma
2015-10-13,Inotek Pharmaceuticals Appoints Gary M. Phillips, MD, MBA, To Board Of Directors
2015-08-18,Inotek Pharmaceuticals Corporation Announces Closing Of $79.2 Million Public Offering Including Exercise In Full Of Underwriters' Option To Purchase Additional Shares
2015-08-12,Inotek Pharmaceuticals Corporation Announces Pricing Of $68.9 Million Public Offering
2015-08-06,Inotek Pharmaceuticals Corporation Reports Second Quarter 2015 Financial Results And Operational Highlights
2015-07-30,Inotek Pharmaceuticals Announces Conversion Of $21 Million Principal Amount Of 5.0% Convertible Senior Notes Due 2020
2015-07-27,4 Stocks Spiking on Unusual Volume
2015-07-24,Cramer: Biogen's Horseman May Have Fallen Off, But These 3 Are Better
2015-07-24,Cramer: Biogen's Horseman May Have Fallen Off, I Like Others More
2015-07-23,Market News: 3M, Caterpillar, Inotek Pharmaceuticals
2015-07-23,Inotek Pharmaceuticals Announces Positive End-of-Phase 2 Meeting With FDA And Phase 3 Development Strategy For Trabodenoson, A Novel Treatment For Glaucoma
2015-07-22,Inotek Pharmaceuticals Appoints Dr. Cadmus Collins Rich As Vice President, Medical Affairs And Clinical Development
2015-07-21,Inotek Pharmaceuticals Appoints Richard N. Spivey PharmD, Ph.D. To Board Of Directors
2015-07-20,Inotek Pharmaceuticals Corporation Appoints Claudine Prowse, Ph.D. As Vice President, Strategy And Investor Relations Officer
2015-05-15,Inotek Pharmaceuticals Corporation Reports First Quarter 2015 Operational And Financial Results
2015-04-01,Inotek Pharmaceuticals Corporation Reports 2014 Financial Results
2015-02-18,Inotek Pharmaceuticals Corporation Announces Pricing Of Initial Public Offering Of 6,667,000 Shares Of Common Stock And 5.0% Convertible Senior Notes Due 2020
,
,
